Aricept Complexed with Acetylcholinesterase (Czech)
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
<StructureSection load='1eve' size='450' side='right' scene='29/2908/1eve_e20_cartoon/1' caption=''> | <StructureSection load='1eve' size='450' side='right' scene='29/2908/1eve_e20_cartoon/1' caption=''> | ||
[[Image:E2020_interactins_in_AChE_gorge.jpg|left|250px]]<br /> | [[Image:E2020_interactins_in_AChE_gorge.jpg|left|250px]]<br /> | ||
- | '''3D struktura léčiva Aricept | + | '''3D struktura léčiva Alzheimerovy choroby Aricept, komplex s acetylcholinesterasou''' |
(viz též [[AChE bivalent inhibitors (Part II)]]) | (viz též [[AChE bivalent inhibitors (Part II)]]) | ||
==Úvod== | ==Úvod== |
Revision as of 12:24, 25 April 2017
|
Reference
Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs., Kryger G, Silman I, Sussman JL, Structure. 1999 Mar 15;7(3):297-307. PMID:10368299
Viz 1eve (Chinese), 1eve (French), 1eve (Arabic), 1eve (Russian), 1eve (Spanish), & 1eve (Turkish).